The purpose of this case report is to highlight the importance of including GPA in the differential diagnosis in the setting of progressive cranial neuropathy, and to emphasize the need for a multidisciplinary approach for timely diagnosis and utilization of immunosuppressive treatment to minimize the chronic effects of the disease. The gene discussed is GYPA; the disease is cranial nerve neuropathy.